三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
在美国,帕博利珠单抗、戈沙妥珠单抗已跻身TNBC治疗的首位推荐
在美国,帕博利珠单抗、戈沙妥珠单抗已跻身TNBC治疗的首位推荐
其它
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:359KB
图片尺寸:2303*1320
同报告图片
/
4
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
fCDmipfkvZPkurLlkozlipsvS0QgfCDoiqblurfmspnlpqXnj6DljZXmipcgfCDmiIjmspnlpqXnj6DljZXmipcgfCDlvrfovr7ljZrlpqXljZXmipcgfAp8LS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tfAp8IOi9veiNtyAgICAgICAgICAgfCBLTDYxMDAyMy/otJ3mtJvmm7/lurfooY3nlJ/niakgfCBTTi0zOC/kvIrnq4vmm7/lurfooY3nlJ/niakgfCBEZXJ1eHRlY2FuL0V4YXRlY2Fu6KGN55Sf54mpIHwKfCDovb3ojbcgSUM1MCAgICAgIHwgMC43IM68bW9sL0wgICAgIHwgMi43OCDOvG1vbC9MICB8IDAuMzEgzrxtb2wvTCAgfAp8IOi/nuaOpeWtkCAgICAgICAgIHwg5ZCrMi3nlLLno7rphbDln7rlr4bllbbnmoQgQ0wyQSB8IOWQq+mprOadpemFsOS6muiDuueahCBDTDJBIHwgR0dGR++8iOWbm+iCve+8iSB8Cnwg6KGA5rWG56iz5a6a5oCnICAgICB8IDE0NGgg6YeK5pS+IDcwJSAgfCA0OGgg6YeK5pS+IDEwMCUgfCAzIOWRqOmHiuaUviAxLjQtNS41JSB8Cnwg5YG26IGU5pa55byPICAgICAgIHwg5LiN5Y+v6YCG55qE5L2N54K554m55byC5oCn55Sy56O66YWw5Z+65a+G5ZW2Leehq+mGh+WBtuiBlCB8IOWPr+mAhueahOS9jeeCueeJueW8guaAp+mprOadpemFsOS6muiDui3noavphoflgbbogZQgfCDlj6/pgIbnmoTkvY3ngrnpgInmi6nmgKfpqazmnaXphbDkuprog7ot56Gr6YaH5YG26IGUIHwKfCDoo4Lop6PmlrnlvI8gICAgICAgfCBwSCDkvp3otZYv6YW25YiHICAgfCBwSCDkvp3otZYv6YW25YiHICB8IOmFtuWIhyAgICAgICAgICB8Cnwg5Y2K6KGw5pyfICAgICAgICAgfCAzNiBoICAgICAgICAgICB8IDExLjQgaCAgICAgICB8IDExMC40IGggICAgICB8CnwgREFSICAgICAgICAgICAgfCA3LjQgICAgICAgICAgICB8IDcuNiAgICAgICAgICB8IDQgICAgICAgICAgICB8Cnwg5oqX5L2T5Lqy5ZKM5Yqb5a+55q+UIHwg5oiI5rKZ5aal54+g5Y2V5oqXIOKJiCDoiqblurfmspnlpqXnj6DljZXmipcgPiDlvrfovr7ljZrlpqXljZXmipcgfAp8IOi9veiNt+avkuaAp+WvueavlCAgIHwg5b636L6+5Y2a5aal5Y2V5oqXID4g6Iqm5bq35rKZ5aal54+g5Y2V5oqXID4g5oiI5rKZ5aal54+g5Y2V5oqXIHwKfCDov57mjqXlrZDnqLPlrprmgKflr7nmr5QgfCDlvrfovr7ljZrlpqXljZXmipcgPiDoiqblurfmspnlpqXnj6DljZXmipcgPiDmiIjmspnlpqXnj6DljZXmipcgfAoK6LWE5paZ5p2l5rqQ77ya5YWs5Y+45oub6IKh6K+05piO5Lmm77yM44CKRGF0b3BvdGFtYWIgRGVydXh0ZWNhbiwgYSBOb3ZlbCBUUk9QMi1kaXJlY3RlZCBBbnRpYm9keS1kcnVnIENvbmp1Z2F0ZSwgRGVtb25zdHJhdGVzIFBvdGVudCBBbnRpdHVtb3LjgIs=
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
所属报告:
科伦博泰生物~B-港股公司首次覆盖报告:锋芒初显中国ADC龙头逐鹿全球市场-240723(47页).pdf
打包全文图表
相关数据
图表13一线TNBC不同疗法ORR对比
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
收藏
行业数据
2026-02-28
原图定位
查看详情
图表14一线TNBC不同疗法mPFS(月)对比
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
收藏
行业数据
2026-02-28
原图定位
查看详情
全球首个FGFR4抑制剂联合IO在HCC的临床设计:依帕戈替尼联合阿替利珠单抗的临床二期试验方案
PHxiZWdpbl9vZl9ib3h8PnwgUGFydCB8IERvc2UgUmVnaW1lbiAgICAgICB8IFNhbXBsZSBTaXplIChOKSB8CnwtLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS18CnwgQSAgICB8IDE4MG1nIFFEICAgICAgICAgICB8IDYgICAgICAgICAgICAgICB8CnwgQSAgICB8IDMyMG1nIFFEICAgICAgICAgICB8IDYgICAgICAgICAgICAgICB8CnwgQSAgICB8IDE2MG1nIEJJRCAgICAgICAgICB8IDggICAgICAgICAgICAgICB8CnwgQSAgICB8IDIyMG1nIEJJRCAgICAgICAgICB8IDMzICAgICAgICAgICAgICB8CgrotYTmlpnmnaXmupDvvJrlhazlj7hQUFQ8fGVuZF9vZl9ib3h8Pg==
收藏
行业数据
2025-10-10
原图定位
查看详情
帕博利珠单抗(K药)、纳武利尤单抗(O药)全球销售额情况(单位:十亿美元)
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
收藏
行业数据
2025-09-23
原图定位
查看详情
TNBC不论PD-L1表达的状况下,依沃西单抗及PM8002在ORR数据以及安全性数据上都显示出优效
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
收藏
行业数据
2025-07-17
原图定位
查看详情
PD-(L)1及TROP2靶点在TNBC的治疗格局中的重要性高
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
收藏
竞争格局
2025-07-17
原图定位
查看详情
SKB264TNBC适应症新增纳入2025CSCO乳腺癌诊疗指南
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
收藏
行业数据
2025-06-30
原图定位
查看详情
纳武利尤单抗和帕博利珠单抗全球销售额(2014-2024)
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
收藏
行业数据
2025-06-30
原图定位
查看详情
SSGJ-707及帕博利珠单抗联合化疗一线治疗NSCLC疗效及安全性
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
收藏
行业数据
2025-06-20
原图定位
查看详情
SSGJ-707及帕博利珠单抗单药一线治疗PD-L1阳性NSCLC疗效及安
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
收藏
行业数据
2025-06-20
原图定位
查看详情
TROP2ADC替代化疗与IO疗法联用前线治疗TNBC
fCDkuprlnosgfCDoja/niakgICAgIHwg5oiI5rKZ5aal54+g5Y2V5oqX77yIVHJvZGVsdnnvvIkgICAgICAgfCDoiqbms7DlpqXnj6DljZXmipfvvIjkvbPlpYjms7DvvIkgICAgICAgICB8IOW+t+i+vuWNmuWmpeePoOWNleaKl++8iERhaXdhee+8iSAgICAgICAgIHwKfC0tLS0tLXwtLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfAp8IOi+heWKqSB8ICAgICAgICAgIHwgQVNDRU5ULTA1LCBWUy4g5Y2h5Z+55LuW5ruoICAgICAgICB8IE1LLTI4NzAtMDEyLCBWUy4gS+iNr+iBlOWQiOWMlueWlyAgIHwgVFJPUElPTi1icmVhc3QwMywgVlMuIElDVCAgICAgIHwKfCAgICAgIHwgICAgICAgICAgfCBJSUnmnJ8sIOmihOiuoeWujOaIkDogMjAyNy0wNiAgICAgICB8IElJSeacnywg6aKE6K6h5a6M5oiQOiAyMDMwLTEyICAgICAgIHwgSUlJ5pyfLCDpooTorqHlrozmiJA6IDIwMjctMDkgICAgICAgfAp8ICAgICAgfCAgICAgICAgICB8ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IOOAkOacr+WQjui+heWKqeOAkeiBlOWQiEvoja/lj4rljJbnlpcgICAgICB8IOOAkOacr+WQjui+heWKqeOAkeiBlOWQiGR1cnZhbHVtYWIgICAgICB8CnwgICAgICB8ICAgICAgICAgIHwgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgTUstMjg3MC0wMzIsIFZTLiBL6I2v6IGU5ZCI5YyW55aXICAgfCBUUk9QSU9OLUJyZWFzdDA0IFZTLkvoja8gICAgICAgIHwKfCAgICAgIHwgICAgICAgICAgfCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCBJSUnmnJ8sIOmihOiuoeWujOaIkDogMjAzMy0wMyAgICAgICB8IElJSeacnywg6aKE6K6h5a6M5oiQOiAyMDI4LTAzICAgICAgIHwKfCAgICAgIHwgICAgICAgICAgfCDjgJBQRC1MMS3jgJHljZXoja8gICAgICAgICAgICAgICAgICB8IOOAkFBELUwxIENQUzwxMOOAkeWNleiNr+aIluiBlOWQiEvoja8gIHwg44CQ5LiN6YCC5ZCIUEQtKEwxKeayu+eWl+eahFROQkPjgJHljZXoja8gfAp8ICAgICAgfCAgICAgICAgICB8IEFTQ0VOVC0wMywgVlMuIFRQQyAgICAgICAgICAgICB8IE1LLTI4NzAtMDExLCBWUy4g5YyW55aXICAgICAgICAgIHwgVFJPUElPTi1CcmVhc3QwMiBWUy4gSUNDICAgICAgIHwKfCAgICAgIHwgICAgICAgICAgfCBJSUnmnJ8sIOmihOiuoeWujOaIkDogMjAyOC0wNyAgICAgICB8IElJSeacnywg6aKE6K6h5a6M5oiQOiAyMDMwLTA1ICAgICAgIHwgSUlJ5pyfLCDpooTorqHlrozmiJA6IDIwMjUtMTIgICAgICAgfAp8ICAgICAgfCAgICAgICAgICB8IOOAkFBELUwxK+OAkeiBlOWQiEvoja8gICAgICAgICAgICAgICB8IOOAkDFM5rK755aXVE5CQ+OAkeWNleiNryAgICAgICAgICAgICB8IOOAkFBELUwxK+OAkeiBlOWQiER1cnZhbHVtYWIgICAgICAgIHwKfCAgICAgIHwgICAgICAgICAgfCBBU0NFTlQtMDQsIFZTLiBUUEMgICAgICAgICAgICAgfCBTS0IyNjQtSUlJLTExLCBWUy4g5YyW55aXICAgICAgICB8IFRST1BJT04tQnJlYXN0MDUgVlMuIOWMlueWl+iBlOWQiEvoja98CnwgICAgICB8ICAgICAgICAgIHwgSUlJ5pyfLCDpooTorqHlrozmiJA6IDIwMjctMDIgICAgICAgfCBJSSAvSUlJ5pyfLCDpooTorqHlrozmiJA6IDIwMjYtMDcgICB8IElJSeacnywg6aKE6K6h5a6M5oiQOiAyMDI2LTA5ICAgICAgIHwKfCDlkI7nur8gIHwgICAgICAgICAgfCDjgJDlhajnkIPvvIwzTOOAkeWNleiNryAgICAgICAgICAgICAgICB8IOOAkOS4reWbve+8jDNM44CR5Y2V6I2vICAgICAgICAgICAgICAgIHwgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCAgICAgIHwgICAgICAgICAgfCBBU0NFTlQsIFZTLiDljJbnlpcgICAgICAgICAgICAgICB8IFNLQjI2NC1JSUktMDMsIFZTLiDljJbnlpcgICAgICAgIHwgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCAgICAgIHwgICAgICAgICAgfCDlt7LkuIrluIIgICAgICAgICAgICAgICAgICAgICAgICAgIHwg5bey5LiK5biCICAgICAgICAgICAgICAgICAgICAgICAgICB8ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CgrotYTmlpnmnaXmupDvvJpDbGluaWNhbHRyaWFscy5nb3YsIOWbvemHkeivgeWIuOeglOeptuaJgA==
收藏
行业数据
2025-06-03
原图定位
查看详情
HR+/HER2-BC患者数占比高但预后好,HER2+BC及TNBC侵袭性更强
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
收藏
行业数据
2025-06-03
原图定位
查看详情
PD-(L)1免疫疗法需联合化疗才能在TNBC中展现较好疗效
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
收藏
行业数据
2025-06-03
原图定位
查看详情
帕博利珠单抗在PD-(L)1全球市场占主导地位(单位:亿美元)
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
收藏
行业数据
2025-06-03
原图定位
查看详情
帕博利珠单抗自2023年成为全球最畅销药品Top1(单位:亿美元)
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
收藏
行业数据
2025-06-03
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
美国市场先行:PD-1+化疗及 ADC 已站稳脚跟,成为指南首位推荐。帕博利珠单抗用于高危 TNBC 的辅助治疗、PD-L1 阳性 TNBC 的一线治疗两项适应症均已成为 NCCN 的首选治疗方案;在 ADC 领域,德曲妥珠单抗为HER2 低表达人群二线及以上的首选方案,而戈沙妥珠单抗为全人群二线及以上的首选方案。
其它
原图定位
当前图表所属:
科伦博泰生物~B-港股公司首次覆盖报告:锋芒初显中国ADC龙头逐鹿全球市场-240723(47页).pdf
新版CSCO指南中PD-1抑制剂的地位快速提升,TROP2ADC戈沙妥珠单抗初步跻身后线治疗
各TROP2ADC结构设计各异,芦康沙妥珠单抗的毒性及稳定性较为均衡,带来性能优势
全球多款ADC获批,作用机制高度多元化
相对估值法:市值/累计研发投入测算:合理股权价值246.03港元/股
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》